Susie Lisa | executive |
Reshma Kewalramani | executive |
Stuart Arbuckle | executive |
Charles Wagner | executive |
Geoffrey Meacham | analyst |
Robyn Karnauskas | analyst |
Salveen Richter | analyst |
Philip Nadeau | analyst |
Mohit Bansal | analyst |
Jessica Fye | analyst |
David Risinger | analyst |
Evan Seigerman | analyst |
Liisa Bayko | analyst |
Michael Yee | analyst |
Terence Flynn | analyst |
Good day, and welcome to the Vertex Pharmaceuticals Third Quarter 2023 Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Ms. Susie Lisa. Please go ahead, ma'am.
Good evening, all. My name is Susie Lisa, and as the Senior Vice President of Investor Relations, it is my pleasure to welcome you to our third quarter 2023 financial results conference call.